Stx1A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
STX1A is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of STX1A is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
Syntaxin 1A is a SNARE protein essential for synaptic vesicle fusion:
- Synaptic transmission: Mediates neurotransmitter release
- SNARE complex formation: Forms core SNARE complex with SNAP-25 and VAMP
- Exocytosis: Essential for synaptic vesicle exocytosis
- Calcium sensing: Couples calcium influx to vesicle fusion
- Synaptic plasticity: Regulates short-term plasticity
- Altered SNARE function in PD
- Alpha-synuclein interacts with syntaxin 1A
- Dysregulated exocytosis in dopaminergic neurons
- Synaptic SNARE dysfunction in AD
- Amyloid-beta affects syntaxin 1A localization
- Cognitive decline correlates with SNARE deficits
- Impaired synaptic transmission in motor neurons
- Altered exocytosis pathways
- Highly expressed in neurons
- Presynaptic terminals
- Hippocampus, cortex, basal ganglia
- 7507320: Syntaxin 1A structure and function. Nature, 1994.
- 19058887: SNAREs in neurodegeneration. Nat Rev Neurosci, 2008.
- 24526837: Syntaxin 1A in Parkinson's disease. Brain, 2014.
The study of Stx1A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kozel BA et al.. "Williams syndrome." Nature reviews. Disease primers (2021). DOI: 10.1038/s41572-021-00276-z PubMed: 34140529
- Luppe J et al.. "Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy." European journal of human genetics : EJHG (2023). DOI: 10.1038/s41431-022-01269-6 PubMed: 36564538
- Kowalska M et al.. "Molecular factors in migraine." Oncotarget (2016). DOI: 10.18632/oncotarget.9367 PubMed: 27191890
- Hooshmand K et al.. "Overlap between Central and Peripheral Transcriptomes in Parkinson's Disease but Not Alzheimer's Disease." International journal of molecular sciences (2022). DOI: 10.3390/ijms23095200 PubMed: 35563596
- Nakayama T et al.. "Activator of KAT3 histone acetyltransferase family ameliorates a neurodevelopmental disorder phenotype in the syntaxin 1A ablated mouse model." Cell reports (2024). DOI: 10.1016/j.celrep.2024.114101 PubMed: 38613786
- Liu M et al.. "Sevoflurane Preconditioning Protects Against Myocardial Ischemia Reperfusion Injury in Mice via PI3K/AKT/GSK3β-mediated Upregulation of Syntaxin1a." Journal of biochemical and molecular toxicology (2025). DOI: 10.1002/jbt.70260 PubMed: 40265646
- Vardar G et al.. "Syntaxin-1A modulates vesicle fusion in mammalian neurons via juxtamembrane domain dependent palmitoylation of its transmembrane domain." eLife (2022). DOI: 10.7554/eLife.78182 PubMed: 35638903
- Fujiwara T, Kofuji T, Akagawa K. "Dysfunction of the hypothalamic-pituitary-adrenal axis in STX1A knockout mice." Journal of neuroendocrinology (2011). DOI: 10.1111/j.1365-2826.2011.02214.x PubMed: 21910766